EU cracks down on blood pressure medicine made by Mylan
Updated : November 20, 2018 12:17 PM IST
The European regulator said the unit's compliance certificate had been suspended, effectively prohibiting the use of its valsartan in medicines in the region.
The affected batches are being recalled and tests conducted to determine the extent of the contamination, the European Medicines Agency said on Monday.
The US Food and Drug Administration last month halted imports of drug ingredients or medicines made with ingredients produced at a factory belonging to a Chinese bulk manufacturer of valsartan, Zhejiang Huahai Pharmaceuticals.